Online citations, reference lists, and bibliographies.
← Back to Search

Staphylococcus Aureus In The Lesions Of Atopic Dermatitis

J. Leyden, R. Marples, A. Kligman
Published 1974 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Quantitative aerobic cultures were obtained from fifty patients with chronic plaques, and from twenty with exudative lesions of atopic dermatitis. In the former, Staphylococcus aureus was isolated from 90% and the density exceeded 1 × 106/cm2 in 45% of the samples. In the exudative form, Staph. aureus was recovered in every case with a mean density of 14 × 106 organisms per cm2. Staph. aureus was the dominant organism not only in the lesions but in nearby clinically normal skin. Despite these high numbers, clinical signs of infection were lacking. Systemic and topical antibiotic therapy pro‐duced a profound decrease in Staph. aureus density.
This paper references



This paper is referenced by
10.1101/2021.03.24.436824
On-person adaptive evolution of Staphylococcus aureus during atopic dermatitis increases disease severity
F. Key (2021)
10.3390/biomedicines9030266
Dysbiosis and Enhanced Beta-Defensin Production in Hair Follicles of Patients with Lichen Planopilaris and Frontal Fibrosing Alopecia
A. Constantinou (2021)
10.1001/jamadermatol.2021.1311
Use of Autologous Bacteriotherapy to Treat Staphylococcus aureus in Patients With Atopic Dermatitis: A Randomized Double-blind Clinical Trial.
T. Nakatsuji (2021)
10.1038/s41591-021-01256-2
Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial.
T. Nakatsuji (2021)
10.2141/jpsa.0200062
A Comparative Study on Egg Yolk IgY Production with Different Adjuvants and their Inhibitory Effects on Staphylococcus aureus
Nanase Kubo (2021)
10.1111/exd.14446
The power and potential of BIOMAP to elucidate host‐microbiome interplay in skin inflammatory diseases
H. Alenius (2021)
10.1097/PRS.0000000000007621
Temporal Variation of the Facial Skin Microbiome: A 2-Year Longitudinal Study in Healthy Adults.
G. Hillebrand (2021)
10.3389/fimmu.2021.621754
Safety and Immunogenicity of a 4-Component Toxoid-Based Staphylococcus aureus Vaccine in Rhesus Macaques
A. Venkatasubramaniam (2021)
10.3390/microorganisms9020353
Gut–Skin Axis: Current Knowledge of the Interrelationship between Microbial Dysbiosis and Skin Conditions
Britta De Pessemier (2021)
10.1111/jdv.17272
Topical therapy of atopic dermatitis with a focus on pimecrolimus
T. Luger (2021)
10.1007/978-981-15-6552-6_33
Rhegmatogenous Retinal Detachments in the Pediatric Population and Special Considerations for Pediatric Vitreoretinal Surgery
N. Gan (2021)
10.1080/21505594.2021.1975909
Phenol-soluble modulins α are major virulence factors of Staphylococcus aureus secretome promoting inflammatory response in human epidermis
Alexia Damour (2021)
10.1111/exd.14435
Updated understanding of Staphylococcus aureus in atopic dermatitis: From virulence factors to commensals and clonal complexes
Jonwei Hwang (2021)
10.1159/000515236
Shifts in the Skin Microbiota after UVB Treatment in Adult Atopic Dermatitis.
Astrid Haaskjold Lossius (2021)
10.1038/s41598-021-93941-y
Prospective, comparative clinical pilot study of cold atmospheric plasma device in the treatment of atopic dermatitis
Young Jae Kim (2021)
10.1264/jsme2.ME20037
Does the Gut Microbiota Modulate Host Physiology through Polymicrobial Biofilms?
Jiayue Yang (2020)
10.3389/fcimb.2020.614446
Cutaneous Malassezia: Commensal, Pathogen, or Protector?
Shree Harsha Vijaya Chandra (2020)
10.1016/j.jaci.2019.11.004
The skin microbiome as a clinical biomarker in atopic eczema: Promises, navigation, and pitfalls.
M. Reiger (2020)
10.2174/2210681209666181226153741
Developmental Studies of Curcumin NLCs as Safe Alternative in Management of Infectious Childhood Dermatitis
M. Lalan (2020)
Centenary theme section : ATOPIC DERMATITIS
S. Edslev (2020)
10.1016/j.celrep.2020.02.021
Interplay of Staphylococcal and Host Proteases Promotes Skin Barrier Disruption in Netherton Syndrome
Michael R Williams (2020)
10.1007/s13671-020-00297-z
The Skin Microbiome in Inflammatory Skin Diseases
L. B. Nørreslet (2020)
10.5530/IJOPP.13.2.22
Evaluation and Management of Atopic Dermatitis
J. Kirubakaran (2020)
10.1016/j.jaci.2020.06.024
Staphylococcus epidermidis protease EcpA can be a deleterious component of the skin microbiome in atopic dermatitis.
L. Cau (2020)
10.1016/j.jaip.2019.12.005
Halting the March: Primary Prevention of Atopic Dermatitis and Food Allergies.
F. Bawany (2020)
10.1002/9781119593058.ch9
Dysbiosis of the Skin Microbiome in Atopic Dermatitis
Joyce Y Cheng (2020)
10.1016/j.bbrc.2020.08.029
Staphylococcal superantigen-like 12 induces the production of interleukin 4 in murine basophils.
Saishi Nishiyama (2020)
10.1097/DER.0000000000000589
Staphylococcus aureus in Atopic Dermatitis: Past, Present, and Future
Jonwei Hwang (2020)
10.1111/exd.14185
Stratum corneum lipidomics analysis reveals altered ceramide profile in atopic dermatitis patients across body sites with correlated changes in skin microbiome
H. Emmert (2020)
10.1016/j.mehy.2020.109637
Sleep disturbance and atopic dermatitis: A bidirectional relationship?
E. M. Xerfan (2020)
10.1016/j.jaci.2020.09.031
Atopic dermatitis microbiomes stratify into ecological dermotypes enabling microbial virulence and disease severity.
A. Tay (2020)
10.1016/S0140-6736(20)31286-1
Atopic dermatitis
S. Langan (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar